Ignite Creation Date:
2025-12-24 @ 4:04 PM
Ignite Modification Date:
2026-01-22 @ 8:38 AM
Study NCT ID:
NCT03670966
Status:
RECRUITING
Last Update Posted:
2025-10-16
First Post:
2018-09-12
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
211At-BC8-B10 Followed by Donor Stem Cell Transplant in Treating Patients With Relapsed or Refractory High-Risk Acute Leukemia or Myelodysplastic Syndrome
Sponsor:
Fred Hutchinson Cancer Center
Organization:
Conditions & Keywords Data
Conditions:
Conditions
| Condition Brief | Condition Text | View |
|---|---|---|
| None | Acute Lymphoblastic Leukemia in Remission | View |
| None | Acute Myeloid Leukemia Arising From Previous Myelodysplastic Syndrome | View |
| None | Acute Myeloid Leukemia in Remission | View |
| None | Chronic Myelomonocytic Leukemia | View |
| None | Myelodysplastic Syndrome With Excess Blasts | View |
| None | Recurrent Acute Lymphoblastic Leukemia | View |
| None | Recurrent Acute Myeloid Leukemia | View |
| None | Refractory Acute Lymphoblastic Leukemia | View |
| None | Refractory Acute Myeloid Leukemia | View |
| None | Recurrent Mixed Phenotype Acute Leukemia | View |
| None | Refractory Mixed Phenotype Acute Leukemia | View |
| None | Hematopoietic and Lymphoid Cell Neoplasm | View |